Wednesday, August 19, 2026
22.2 C
Bengaluru

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial strategy, supply chain management, procurement, operations, and sustainability, Rajesh brings a strong track record of driving transformation and growth across global markets.

Before joining ACG, Rajesh held several leadership positions at EPL Ltd. (Essel Propack Ltd.), where he led global supply chain and sustainability initiatives across multiple countries. His career also includes significant leadership experience at BASF India and Asian Paints, where he contributed to large-scale initiatives spanning supply chain transformation, strategic procurement, operational excellence, digitalisation, inventory optimisation, and cost transformation.

In his new role as Chief Commercial Officer, Rajesh will lead ACG’s global commercial strategy, strengthen strategic partnerships, support market expansion, and drive initiatives focused on commercial excellence and sustainable growth.

His diverse experience across manufacturing, chemicals, packaging, and consumer-focused industries positions him to bring a broad business perspective as ACG continues to strengthen its global presence across pharmaceutical and nutraceutical manufacturing solutions.

MedicinMan congratulates Rajesh Bhogavalli on this new leadership role and wishes him continued success.

Hot this week

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...

Topics

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...

Platforms Are Owning the Patient While Pharma Waits

The future of experimental medicine is not simply a...

Samit Mehta has been appointed Chief Operating Officer (COO) of Emcure Pharmaceuticals Ltd.

Samit Mehta brings extensive experience in healthcare leadership, business...
spot_img

Related Articles

spot_imgspot_img